Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases

The Potential Value of Phosphohistone-H3 Mitotic Index Determined by Digital Image Analysis in the Assessment of Pancreatic Endocrine Tumors in Fine-Needle Aspiration Cytology Specimens

(2013) Rossitza Draganova-Tacheva et al.   ACTA CYTOLOGICA

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

(2013) G Fisher et al.   BRITISH JOURNAL OF CANCER

Ki67 and proliferation in breast cancer

(2013) Nirmala Pathmanathan et al.   JOURNAL OF CLINICAL PATHOLOGY

Phosphohistone-H3 and Ki-67 immunostaining in cutaneous pilar leiomyoma and leiomyosarcoma (atypical intradermal smooth muscle neoplasm)

(2013) Munir H Idriss et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Quick-and-clean article figures with FigureJ

(2013) J. MUTTERER et al.   JOURNAL OF MICROSCOPY

Validity and reproducibility of Ki-67 assessment in gastrointestinal stromal tumors and leiomyosarcomas

(2013) Jiro Ogino et al.   PATHOLOGY INTERNATIONAL

Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System

(2012) Laura H. Tang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

(2012) Zsuzsanna Varga et al.   PLoS One

St. Gallen 2011: Summary of the Consensus Discussion

(2011) Michael Gnant et al.   Breast Care

Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database

(2011) John F. Thompson et al.   JOURNAL OF CLINICAL ONCOLOGY

Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas

(2011) Erica Hightower et al.   Pituitary

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

(2010) Rita G Ladstein et al.   BMC CANCER

Digital stain separation for histological images

(2010) P.J. TADROUS   JOURNAL OF MICROSCOPY

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions

(2009) Michel R Nasr et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases

(2009) Shintaro Fukushima et al.   Brain Tumor Pathology

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

(2008) Giuseppe Viale et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

(2008) Giuseppe Viale et al.   JNCI-Journal of the National Cancer Institute